(Q43220825)

16 November 2017

Neuropeptide Y (NPY) suppresses yohimbine-induced reinstatement of alcohol seeking (English)

1 reference

16 November 2017

5

1 reference

16 November 2017

7

1 reference

16 November 2017

Andrea Cippitelli

1

1 reference

16 November 2017

Ruslan Damadzic

2

1 reference

16 November 2017

Anita C Hansson

3

1 reference

16 November 2017

Erick Singley

4

1 reference

16 November 2017

Robert Eskay

6

1 reference

16 November 2017

Markus Heilig

8

1 reference

16 November 2017

10 December 2009

1 reference

16 November 2017

1 reference

16 November 2017

208

1 reference

16 November 2017

3

1 reference

16 November 2017

417-426

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-009-1741-y

16 November 2017

0 references

cites work

Effects of neuropeptide Y on sucrose and ethanol intake and on anxiety-like behavior in high alcohol drinking (HAD) and low alcohol drinking (LAD) rats

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-009-1741-Y

Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-009-1741-Y

Interactions between NPY and CRF in the amygdala to regulate emotionality

21 January 2018

1 reference

12 December 2020

Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal.

1 reference

12 December 2020

Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus.

1 reference

12 December 2020

Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats.

1 reference

12 December 2020

Immediate-early gene expression in the central nucleus of the amygdala is not specific for anxiolytic or anxiogenic drugs

1 reference

12 December 2020

Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats

1 reference

12 December 2020

The limbic lobe and its output channels: implications for emotional functions and adaptive behavior

1 reference

12 December 2020

The reinstatement model of drug relapse: history, methodology and major findings

1 reference

12 December 2020

Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms.

1 reference

12 December 2020

Interactions between the neuropeptide Y system and the hypothalamic-pituitary-adrenal axis

1 reference

12 December 2020

The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse

1 reference

12 December 2020

Corticotropin-releasing factor and neuropeptide Y: role in emotional integration

1 reference

12 December 2020

Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder

1 reference

12 December 2020

Neuropeptide Y in the hypothalamus: effect on corticosterone and single-unit activity.

1 reference

12 December 2020

Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats

1 reference

12 December 2020

Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor.

1 reference

12 December 2020

Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism

1 reference

12 December 2020

Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment.

1 reference

12 December 2020

Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine.

1 reference

12 December 2020

Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models

1 reference

12 December 2020

Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats.

1 reference

12 December 2020

Neuroplasticity in brain reward circuitry following a history of ethanol dependence

1 reference

12 December 2020

Ethanol consumption and resistance are inversely related to neuropeptide Y levels

1 reference

12 December 2020

Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants.

1 reference

12 December 2020

The Impact of the Nonpeptide Corticotropin-Releasing Hormone Antagonist Antalarmin on Behavioral and Endocrine Responses to Stress1

1 reference

12 December 2020

A key role for corticotropin-releasing factor in alcohol dependence

1 reference

12 December 2020

Neuropeptide y: role in emotion and alcohol dependence

1 reference

12 December 2020

Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress

1 reference

12 December 2020

Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats

1 reference

12 December 2020

Noradrenergic inputs to the bed nucleus of the stria terminalis and paraventricular nucleus of the hypothalamus underlie hypothalamic-pituitary-adrenal axis but not hypophagic or conditioned avoidance responses to systemic yohimbine.

1 reference

12 December 2020

Viral vector-induced amygdala NPY overexpression reverses increased alcohol intake caused by repeated deprivations in Wistar rats.

1 reference

12 December 2020

Effects of neuropeptide Y and corticotropin-releasing factor on ethanol intake in Wistar rats: interaction with chronic ethanol exposure

1 reference

12 December 2020

Expression of Fos-like immunoreactivity by yohimbine and clonidine in the rat brain

1 reference

12 December 2020

Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence

1 reference

12 December 2020

Brain stress systems in the amygdala and addiction

1 reference

12 December 2020

Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced increases in alcohol drinking

1 reference

12 December 2020

Neuropeptide-Y stimulates CRF-41 release from rat hypothalami in vitro

1 reference

12 December 2020

Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs

1 reference

12 December 2020

The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats.

1 reference

12 December 2020

A New Anatomical Framework for Neuropsychiatric Disorders and Drug Abuse

1 reference

12 December 2020

Expression of Fos protein in various rat brain areas following acute nicotine and diazepam.

1 reference

12 December 2020

Effects of environmental and pharmacological stressors on c-fos and corticotropin-releasing factor mRNA in rat brain: Relationship to the reinstatement of alcohol seeking

1 reference

12 December 2020

α 2 -Adrenoceptor-Mediated Hyperpolarization of Locus Coeruleus Neurons: Intracellular Studies in Vivo

1 reference

12 December 2020

The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats.

1 reference

12 December 2020

Neuropeptide Y (NPY) in alcohol intake and dependence.

1 reference

12 December 2020

Effects of neuropeptide Y on appetitive and consummatory behaviors associated with alcohol drinking in wistar rats with a history of ethanol exposure

1 reference

12 December 2020

Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.

1 reference

12 December 2020

A role for neuropeptide Y in neurobiological responses to ethanol and drugs of abuse

1 reference

12 December 2020

3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism.

1 reference

12 December 2020

The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress

1 reference

12 December 2020

10.1007/S00213-009-1741-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

16 November 2017

0 references

1 reference